世界の精巣がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Testicular Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4948
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、精巣がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、経口剤）、用途別市場規模（病院薬局、小売薬局、専門がんクリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・精巣がん治療の市場動向
・企業の競争状況、市場シェア
・精巣がん治療の種類別市場規模と予測2016-2027（注射剤、経口剤）
・精巣がん治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、専門がんクリニック、その他）
・精巣がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・精巣がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・精巣がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・精巣がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・精巣がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bristol-Myers Squibb Company、Pfizer、Kyowa Hakko Kirin、Accord Healthcare、Sandoz International、Orphan Europe、Baxter、Merck）
・結論

Testicular cancer is one of the most common tumors in urology. Testicular tumors are divided into primary and secondary, most of which are primary, and secondary is extremely rare. Most are malignant tumors, so treatment drugs are important.

Market Analysis and Insights: Global Testicular Cancer Treatment Market
The global Testicular Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Testicular Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Testicular Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Testicular Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Testicular Cancer Treatment market.

Global Testicular Cancer Treatment Scope and Market Size
Testicular Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Testicular Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Injectable
Oral

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Specialty Cancer Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb Company
Pfizer
Kyowa Hakko Kirin
Accord Healthcare
Sandoz International
Orphan Europe
Baxter
Merck

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testicular Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injectable
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testicular Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Specialty Cancer Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Testicular Cancer Treatment Market Perspective (2016-2027)
2.2 Testicular Cancer Treatment Growth Trends by Regions
2.2.1 Testicular Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Testicular Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Testicular Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Testicular Cancer Treatment Industry Dynamic
2.3.1 Testicular Cancer Treatment Market Trends
2.3.2 Testicular Cancer Treatment Market Drivers
2.3.3 Testicular Cancer Treatment Market Challenges
2.3.4 Testicular Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Testicular Cancer Treatment Players by Revenue
3.1.1 Global Top Testicular Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Testicular Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Testicular Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Testicular Cancer Treatment Revenue
3.4 Global Testicular Cancer Treatment Market Concentration Ratio
3.4.1 Global Testicular Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testicular Cancer Treatment Revenue in 2020
3.5 Testicular Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Testicular Cancer Treatment Product Solution and Service
3.7 Date of Enter into Testicular Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Testicular Cancer Treatment Breakdown Data by Type
4.1 Global Testicular Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Testicular Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Testicular Cancer Treatment Breakdown Data by Application
5.1 Global Testicular Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Testicular Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Testicular Cancer Treatment Market Size (2016-2027)
6.2 North America Testicular Cancer Treatment Market Size by Type
6.2.1 North America Testicular Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Testicular Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Testicular Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Testicular Cancer Treatment Market Size by Application
6.3.1 North America Testicular Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Testicular Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Testicular Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Testicular Cancer Treatment Market Size by Country
6.4.1 North America Testicular Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Testicular Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Testicular Cancer Treatment Market Size (2016-2027)
7.2 Europe Testicular Cancer Treatment Market Size by Type
7.2.1 Europe Testicular Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Testicular Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Testicular Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Testicular Cancer Treatment Market Size by Application
7.3.1 Europe Testicular Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Testicular Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Testicular Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Testicular Cancer Treatment Market Size by Country
7.4.1 Europe Testicular Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Testicular Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Testicular Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Testicular Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Testicular Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Testicular Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Testicular Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Testicular Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Testicular Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Testicular Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Testicular Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Testicular Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Testicular Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Testicular Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Testicular Cancer Treatment Market Size (2016-2027)
9.2 Latin America Testicular Cancer Treatment Market Size by Type
9.2.1 Latin America Testicular Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Testicular Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Testicular Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Testicular Cancer Treatment Market Size by Application
9.3.1 Latin America Testicular Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Testicular Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Testicular Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Testicular Cancer Treatment Market Size by Country
9.4.1 Latin America Testicular Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Testicular Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Testicular Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Testicular Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Testicular Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Testicular Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Testicular Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Testicular Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Testicular Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Testicular Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Testicular Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Testicular Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Testicular Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Testicular Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb Company
11.1.1 Bristol-Myers Squibb Company Company Details
11.1.2 Bristol-Myers Squibb Company Business Overview
11.1.3 Bristol-Myers Squibb Company Testicular Cancer Treatment Introduction
11.1.4 Bristol-Myers Squibb Company Revenue in Testicular Cancer Treatment Business (2016-2021)
11.1.5 Bristol-Myers Squibb Company Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Testicular Cancer Treatment Introduction
11.2.4 Pfizer Revenue in Testicular Cancer Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Kyowa Hakko Kirin
11.3.1 Kyowa Hakko Kirin Company Details
11.3.2 Kyowa Hakko Kirin Business Overview
11.3.3 Kyowa Hakko Kirin Testicular Cancer Treatment Introduction
11.3.4 Kyowa Hakko Kirin Revenue in Testicular Cancer Treatment Business (2016-2021)
11.3.5 Kyowa Hakko Kirin Recent Development
11.4 Accord Healthcare
11.4.1 Accord Healthcare Company Details
11.4.2 Accord Healthcare Business Overview
11.4.3 Accord Healthcare Testicular Cancer Treatment Introduction
11.4.4 Accord Healthcare Revenue in Testicular Cancer Treatment Business (2016-2021)
11.4.5 Accord Healthcare Recent Development
11.5 Sandoz International
11.5.1 Sandoz International Company Details
11.5.2 Sandoz International Business Overview
11.5.3 Sandoz International Testicular Cancer Treatment Introduction
11.5.4 Sandoz International Revenue in Testicular Cancer Treatment Business (2016-2021)
11.5.5 Sandoz International Recent Development
11.6 Orphan Europe
11.6.1 Orphan Europe Company Details
11.6.2 Orphan Europe Business Overview
11.6.3 Orphan Europe Testicular Cancer Treatment Introduction
11.6.4 Orphan Europe Revenue in Testicular Cancer Treatment Business (2016-2021)
11.6.5 Orphan Europe Recent Development
11.7 Baxter
11.7.1 Baxter Company Details
11.7.2 Baxter Business Overview
11.7.3 Baxter Testicular Cancer Treatment Introduction
11.7.4 Baxter Revenue in Testicular Cancer Treatment Business (2016-2021)
11.7.5 Baxter Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Testicular Cancer Treatment Introduction
11.8.4 Merck Revenue in Testicular Cancer Treatment Business (2016-2021)
11.8.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Testicular Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injectable
Table 3. Key Players of Oral
Table 4. Global Testicular Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Testicular Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Testicular Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Testicular Cancer Treatment Market Share by Regions (2016-2021)
Table 8. Global Testicular Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Testicular Cancer Treatment Market Share by Regions (2022-2027)
Table 10. Testicular Cancer Treatment Market Trends
Table 11. Testicular Cancer Treatment Market Drivers
Table 12. Testicular Cancer Treatment Market Challenges
Table 13. Testicular Cancer Treatment Market Restraints
Table 14. Global Testicular Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Testicular Cancer Treatment Market Share by Players (2016-2021)
Table 16. Global Top Testicular Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testicular Cancer Treatment as of 2020)
Table 17. Ranking of Global Top Testicular Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Testicular Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Testicular Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Testicular Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Testicular Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Testicular Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Testicular Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Testicular Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Testicular Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Testicular Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Testicular Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Testicular Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Testicular Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Testicular Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Testicular Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Testicular Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Testicular Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Testicular Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Testicular Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Testicular Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Testicular Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Testicular Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Testicular Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Testicular Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Testicular Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Testicular Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Testicular Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Testicular Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Testicular Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Testicular Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Testicular Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Testicular Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Testicular Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Testicular Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Testicular Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Testicular Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Testicular Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Testicular Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Testicular Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Testicular Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Testicular Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Testicular Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bristol-Myers Squibb Company Company Details
Table 62. Bristol-Myers Squibb Company Business Overview
Table 63. Bristol-Myers Squibb Company Testicular Cancer Treatment Product
Table 64. Bristol-Myers Squibb Company Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 65. Bristol-Myers Squibb Company Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Testicular Cancer Treatment Product
Table 69. Pfizer Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Kyowa Hakko Kirin Company Details
Table 72. Kyowa Hakko Kirin Business Overview
Table 73. Kyowa Hakko Kirin Testicular Cancer Treatment Product
Table 74. Kyowa Hakko Kirin Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 75. Kyowa Hakko Kirin Recent Development
Table 76. Accord Healthcare Company Details
Table 77. Accord Healthcare Business Overview
Table 78. Accord Healthcare Testicular Cancer Treatment Product
Table 79. Accord Healthcare Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 80. Accord Healthcare Recent Development
Table 81. Sandoz International Company Details
Table 82. Sandoz International Business Overview
Table 83. Sandoz International Testicular Cancer Treatment Product
Table 84. Sandoz International Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 85. Sandoz International Recent Development
Table 86. Orphan Europe Company Details
Table 87. Orphan Europe Business Overview
Table 88. Orphan Europe Testicular Cancer Treatment Product
Table 89. Orphan Europe Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 90. Orphan Europe Recent Development
Table 91. Baxter Company Details
Table 92. Baxter Business Overview
Table 93. Baxter Testicular Cancer Treatment Product
Table 94. Baxter Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 95. Baxter Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Revenue in Testicular Cancer Treatment Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Testicular Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Injectable Features
Figure 3. Oral Features
Figure 4. Global Testicular Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Specialty Cancer Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Testicular Cancer Treatment Report Years Considered
Figure 10. Global Testicular Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Testicular Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Testicular Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Testicular Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Testicular Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Testicular Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testicular Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Testicular Cancer Treatment Revenue in 2020
Figure 17. Global Testicular Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Testicular Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Testicular Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Testicular Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Testicular Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Testicular Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Testicular Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Testicular Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Testicular Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Testicular Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Testicular Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Testicular Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Testicular Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Testicular Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Testicular Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Testicular Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Testicular Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Testicular Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 60. Kyowa Hakko Kirin Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 61. Accord Healthcare Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 62. Sandoz International Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 63. Orphan Europe Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 64. Baxter Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Testicular Cancer Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の筋層浸潤性膀胱がん治療市場規模・現状・予測（2021年-2027年）

Global Muscle Invasive Bladder Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5259 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、筋層浸潤性膀胱がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ネオアジュバント化学療法、術後化学療法）、用途別市場規模（病院、研究所、専門クリニック）、主要地域別市場規模（北米、アメリカ、欧州...

世界の腎細胞がん治療市場規模・現状・予測（2021年-2027年）

Global Renal Cell Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5989 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、腎細胞がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、mTOR阻害剤、キナーゼ阻害剤、その他）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の家族性大腸腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5736 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、家族性大腸腺腫症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（...

世界の未分化甲状腺がん市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Market Size, Status and Forecast 2021-2027
QFJ1-3801 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジ...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の乳房乳腺腫瘤摘出術治療市場規模・現状・予測（2021年-2027年）

Global Breast Lumpectomy Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3942 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、乳房乳腺腫瘤摘出術治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（乳がんステージI、乳がんステージII、その他）、用途別市場規模（病院、診療所、外来外科センター、研究所・学術センター、その他）、主...

世界の胃がん検査・治療・予防市場規模・現状・予測（2021年-2027年）

Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2021-2027
QFJ1-3461 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、胃がん検査・治療・予防の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（検査、治療、予防）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…
世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…
世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
世界の筋層浸潤性膀胱がん治療市場規模・現状・予測（2021年-2027年） Muscle invasive bladder cancer is treated by chemotherapy, radiation therapy, or a combination of the two, and anti-cancer treatment is carried out through drugs that kill cancer cells. Market Analysis and Insights: Global Muscle Invasive Bladder Cancer Treatment Market The global Muscle Invasive Bl…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…